Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad MR, Alerany C, Alsina L, Granados EL, Neth O, Poveda JL, Rivière JG, Rodríguez-Gallego C, Tutein Nolthenius JB, Figueiredo R, Labazuy SS, Gil A. Abad MR, et al. Among authors: poveda jl. Glob Reg Health Technol Assess. 2024 May 22;11:124-130. doi: 10.33393/grhta.2024.3041. eCollection 2024 Jan-Dec. Glob Reg Health Technol Assess. 2024. PMID: 38784663 Free PMC article.
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia X, Calleja MÁ, Escudero-Vilaplana V, Pérez-Martínez A, Piñana JL, Poveda JL, Vallès JA. Badia X, et al. Among authors: poveda jl. Orphanet J Rare Dis. 2024 Aug 23;19(1):308. doi: 10.1186/s13023-024-03324-5. Orphanet J Rare Dis. 2024. PMID: 39180132 Free PMC article.
Rationale for combined therapies in severe-to-critical COVID-19 patients.
Gonzaga A, Andreu E, Hernández-Blasco LM, Meseguer R, Al-Akioui-Sanz K, Soria-Juan B, Sanjuan-Gimenez JC, Ferreras C, Tejedo JR, Lopez-Lluch G, Goterris R, Maciá L, Sempere-Ortells JM, Hmadcha A, Borobia A, Vicario JL, Bonora A, Aguilar-Gallardo C, Poveda JL, Arbona C, Alenda C, Tarín F, Marco FM, Merino E, Jaime F, Ferreres J, Figueira JC, Cañada-Illana C, Querol S, Guerreiro M, Eguizabal C, Martín-Quirós A, Robles-Marhuenda Á, Pérez-Martínez A, Solano C, Soria B. Gonzaga A, et al. Among authors: poveda jl. Front Immunol. 2023 Sep 11;14:1232472. doi: 10.3389/fimmu.2023.1232472. eCollection 2023. Front Immunol. 2023. PMID: 37767093 Free PMC article. Review.
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ, Poveda JL, Rivero A, Serra-Baldrich E, Silvestre JF, Armario-Hita JC, Calleja MÁ, Carrascosa JM, Flórez Á, Herranz P, Comellas M, Ortiz de Frutos FJ. Pereyra-Rodríguez JJ, et al. Among authors: poveda jl. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e59-e62. doi: 10.1111/jdv.19432. Epub 2023 Aug 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37594914 No abstract available.
How can artificial intelligence optimize value-based contracting?
Poveda JL, Bretón-Romero R, Del Rio-Bermudez C, Taberna M, Medrano IH. Poveda JL, et al. J Pharm Policy Pract. 2022 Nov 18;15(1):85. doi: 10.1186/s40545-022-00475-3. J Pharm Policy Pract. 2022. PMID: 36401303 Free PMC article.
75 results